A detailed history of Hrt Financial LP transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 126,859 shares of VERV stock, worth $731,976. This represents 0.0% of its overall portfolio holdings.

Number of Shares
126,859
Holding current value
$731,976
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$4.4 - $7.86 $558,179 - $997,111
126,859 New
126,859 $613,000
Q4 2023

Feb 09, 2024

BUY
$8.84 - $18.7 $196,840 - $416,392
22,267 New
22,267 $310,000
Q2 2023

Aug 11, 2023

SELL
$13.34 - $19.9 $16,848 - $25,133
-1,263 Reduced 9.07%
12,669 $237,000
Q1 2023

May 12, 2023

BUY
$14.3 - $24.01 $199,227 - $334,507
13,932 New
13,932 $200,000
Q2 2022

Aug 12, 2022

BUY
$11.14 - $23.17 $407,066 - $846,654
36,541 New
36,541 $558,000
Q3 2021

Nov 15, 2021

SELL
$46.0 - $73.99 $2.86 Million - $4.6 Million
-62,159 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$31.92 - $60.25 $1.98 Million - $3.75 Million
62,159 New
62,159 $3.75 Million

Others Institutions Holding VERV

About Verve Therapeutics, Inc.


  • Ticker VERV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,942,300
  • Market Cap $346M
  • Description
  • Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...
More about VERV
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.